Common Stock, Shares, Outstanding of Lexaria Bioscience Corp. from 31 Oct 2010 to 30 Nov 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Lexaria Bioscience Corp. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Oct 2010 to 30 Nov 2025.
  • Lexaria Bioscience Corp. Common Stock, Shares, Outstanding for the quarter ending 30 Nov 2025 was 22,225,846, a 27% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Lexaria Bioscience Corp. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 22,225,846 +4,773,252 +27% 30 Nov 2025 10-Q 13 Jan 2026 2026 Q1
Q3 2025 19,559,179 0 0% 31 Aug 2025 10-K 28 Nov 2025 2025 FY
Q2 2025 19,459,179 +3,648,974 +23% 31 May 2025 10-Q 14 Jul 2025 2025 Q3
Q1 2025 17,449,179 +5,061,506 +41% 28 Feb 2025 10-Q 14 Apr 2025 2025 Q2
Q4 2024 17,452,594 +7,140,953 +69% 30 Nov 2024 10-Q 10 Jan 2025 2025 Q1
Q3 2024 19,559,179 +11,467,529 +142% 31 Aug 2024 10-Q 13 Jan 2026 2026 Q1
Q2 2024 15,810,205 +7,718,555 +95% 31 May 2024 10-Q 12 Jul 2024 2024 Q3
Q1 2024 12,387,673 +6,436,675 +108% 29 Feb 2024 10-Q 09 Apr 2024 2024 Q2
Q4 2023 10,311,641 +4,360,643 +73% 30 Nov 2023 10-Q 12 Jan 2024 2023 Q1
Q3 2023 8,091,650 +2,140,652 +36% 31 Aug 2023 10-K 26 Nov 2024 2024 FY
Q2 2023 8,091,650 +2,140,652 +36% 31 May 2023 10-Q 14 Jul 2023 2023 Q3
Q1 2023 5,950,998 0 0% 28 Feb 2023 10-Q 14 Apr 2023 2023 Q2
Q4 2022 5,950,998 +224,299 +3.9% 30 Nov 2022 10-Q/A 18 Jan 2023 2023 Q1
Q3 2022 5,950,998 +224,299 +3.9% 31 Aug 2022 10-K 20 Nov 2023 2023 FY
Q2 2022 5,950,998 +846,666 +17% 31 May 2022 10-Q 14 Jul 2022 2022 Q3
Q1 2022 5,950,998 +846,666 +17% 28 Feb 2022 10-Q 11 Apr 2022 2022 Q2
Q4 2021 5,726,699 +2,725,223 +91% 30 Nov 2021 10-Q 14 Jan 2022 2022 Q1
Q3 2021 5,726,699 +2,725,223 +91% 31 Aug 2021 10-K 28 Nov 2022 2022 FY
Q2 2021 5,104,332 -84,482,758 -94% 31 May 2021 10-Q 15 Jul 2021 2021 Q3
Q1 2021 5,104,332 -75,616,547 -94% 28 Feb 2021 10-Q 14 Apr 2021 2021 Q2
Q4 2020 3,001,476 -77,609,403 -96% 30 Nov 2020 10-Q 14 Jan 2021 2021 Q1
Q3 2020 3,001,476 -75,785,658 -96% 31 Aug 2020 10-K 29 Nov 2021 2021 FY
Q2 2020 89,587,090 +11,149,956 +14% 31 May 2020 10-Q 29 Jun 2020 2020 Q3
Q1 2020 80,720,879 +2,718,793 +3.5% 29 Feb 2020 10-Q 03 Apr 2020 2020 Q2
Q4 2019 80,610,879 +3,490,458 +4.5% 30 Nov 2019 10-Q 09 Jan 2020 2020 Q1
Q3 2019 78,787,134 +3,253,663 +4.3% 31 Aug 2019 10-K 15 Oct 2020 2020 FY
Q2 2019 78,437,134 +6,039,829 +8.3% 31 May 2019 10-Q 08 Jul 2019 2019 Q3
Q1 2019 78,002,086 +6,904,781 +9.7% 28 Feb 2019 10-Q 15 Apr 2019 2019 Q2
Q4 2018 77,120,421 +7,685,223 +11% 30 Nov 2018 10-Q 11 Jan 2019 2019 Q1
Q3 2018 75,533,471 +7,557,710 +11% 31 Aug 2018 10-K 14 Nov 2019 2019 FY
Q2 2018 72,397,305 +5,845,002 +8.8% 31 May 2018 10-Q 13 Jul 2018 2018 Q3
Q1 2018 71,097,305 +14,803,826 +26% 28 Feb 2018 10-Q 12 Apr 2018 2018 Q2
Q4 2017 69,435,198 +14,424,189 +26% 30 Nov 2017 10-Q 12 Jan 2018 2018 Q1
Q3 2017 67,975,761 +16,687,284 +33% 31 Aug 2017 10-K 14 Nov 2018 2018 FY
Q2 2017 66,552,303 +21,039,021 +46% 31 May 2017 10-Q 14 Jul 2017 2017 Q3
Q1 2017 56,293,479 +11,740,197 +26% 28 Feb 2017 10-Q 14 Apr 2017 2017 Q2
Q4 2016 55,011,009 +15,058,025 +38% 30 Nov 2016 10-Q 13 Jan 2017 2017 Q1
Q3 2016 51,288,477 +7,450,195 +17% 31 Aug 2016 10-K 27 Nov 2017 2017 FY
Q2 2016 45,513,282 +5,830,298 +15% 31 May 2016 10-Q 13 Jul 2016 2016 Q3
Q1 2016 44,553,282 +9,870,298 +28% 29 Feb 2016 10-Q 13 Apr 2016 2016 Q2
Q4 2015 39,952,984 +5,508,094 +16% 30 Nov 2015 10-Q 08 Jan 2016 2016 Q1
Q3 2015 43,838,282 +9,588,592 +28% 31 Aug 2015 10-K 29 Nov 2016 2016 FY
Q2 2015 39,682,984 +6,858,320 +21% 31 May 2015 10-Q 14 Jul 2015 2015 Q3
Q1 2015 34,682,984 +2,843,320 +8.9% 28 Feb 2015 10-Q 14 Apr 2015 2015 Q2
Q4 2014 34,444,890 +17,513,438 +103% 30 Nov 2014 10-Q 14 Jan 2015 2015 Q1
Q3 2014 34,249,690 +17,818,238 +108% 31 Aug 2014 10-K 27 Nov 2015 2015 FY
Q2 2014 32,824,664 +16,393,212 +100% 31 Jul 2014 10-Q 14 Nov 2014 2014 Q3
Q1 2014 31,839,664 +15,408,212 +94% 30 Apr 2014 10-Q 12 Jun 2014 2014 Q2
Q4 2013 16,931,452 +500,000 +3% 31 Jan 2014 10-Q 12 Mar 2014 2014 Q1
Q3 2013 16,431,452 0 0% 31 Oct 2013 10-KT 09 Dec 2014 2014 FY
Q2 2013 16,431,452 0 0% 31 Jul 2013 10-Q 10 Sep 2013 2013 Q3
Q1 2013 16,431,452 0 0% 30 Apr 2013 10-Q 12 Jun 2013 2013 Q2
Q4 2012 16,431,452 0 0% 31 Jan 2013 10-Q 13 Mar 2013 2013 Q1
Q3 2012 16,431,452 0 0% 31 Oct 2012 10-K 24 Jan 2014 2013 FY
Q2 2012 16,431,452 +800,000 +5.1% 31 Jul 2012 10-Q 12 Sep 2012 2012 Q3
Q1 2012 16,431,452 30 Apr 2012 10-Q 07 Jun 2012 2012 Q2
Q4 2011 16,431,452 31 Jan 2012 10-Q 13 Mar 2012 2012 Q1
Q3 2011 16,431,452 +3,505,104 +27% 31 Oct 2011 10-K 29 Jan 2013 2012 FY
Q2 2011 15,631,452 31 Jul 2011 10-Q 14 Sep 2011 2011 Q3
Q3 2010 12,926,348 31 Oct 2010 10-K 30 Jan 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.